Lmr Partners LLP Regeneron Pharmaceuticals, Inc. Transaction History

Lmr Partners LLP

$10.9 Billion
Q3 2024

A detailed history of Lmr Partners LLP transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Lmr Partners LLP holds 229 shares of REGN stock, worth $162,590. This represents 0.0% of its overall portfolio holdings.

Number of Shares

229

Holding current value

$162,590

% of portfolio

0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 07, 2024	BUY	$1024.09 - $1201.76 $234,516 - $275,203	229 New	229 $240,000
Q1 2024 May 15, 2024	BUY	$902.69 - $993.35 $25,275 - $27,813	28 Added 16.57%	197 $189,000
Q4 2023 Feb 14, 2024	SELL	$775.18 - $881.7 $253,483 - $288,315	-327 Reduced 65.93%	169 $148,000
Q3 2023 Nov 14, 2023	SELL	$692.45 - $844.37 $219,506 - $267,665	-317 Reduced 38.99%	496 $408,000
Q2 2023 Aug 14, 2023	BUY	$700.03 - $830.35 $569,124 - $675,074	813 New	813 $584,000
Q4 2022 Feb 14, 2023	BUY	$705.89 - $766.39 $6.89 Million - $7.48 Million	9,766 New	9,766 $7.05 Million
Q2 2022 Aug 15, 2022	BUY	$548.35 - $738.84 $1.16 Million - $1.56 Million	2,111 Added 456.93%	2,573 $1.52 Million
Q1 2022 May 16, 2022	BUY	$595.12 - $698.43 $274,945 - $322,674	462 New	462 $323,000
Q4 2021 Feb 14, 2022	SELL	$543.48 - $670.97 $1.43 Million - $1.77 Million	-2,637 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$574.03 - $680.96 $1.01 Million - $1.2 Million	1,757 Added 199.66%	2,637 $1.6 Million
Q2 2021 Aug 16, 2021	BUY	$472.8 - $558.54 $416,064 - $491,515	880 New	880 $492,000
Q1 2021 May 17, 2021	SELL	$446.73 - $548.2 $725,936 - $890,825	-1,625 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$478.3 - $607.98 $777,237 - $987,967	1,625 New	1,625 $785,000
Q3 2020 Nov 16, 2020	SELL	$544.75 - $658.21 $9.41 Million - $11.4 Million	-17,276 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$493.32 - $643.92 $7.77 Million - $10.1 Million	15,759 Added 1038.83%	17,276 $10.8 Million
Q1 2020 May 15, 2020	SELL	$336.18 - $494.43 $265,246 - $390,105	-789 Reduced 34.22%	1,517 $718,000
Q4 2019 Feb 14, 2020	SELL	$274.13 - $376.51 $397,214 - $545,562	-1,449 Reduced 38.59%	2,306 $865,000
Q3 2019 Nov 14, 2019	BUY	$273.46 - $318.39 $1.03 Million - $1.2 Million	3,755 New	3,755 $1.04 Million
Q2 2018 Aug 03, 2018	SELL	$284.6 - $344.99 $399,863 - $484,710	-1,405 Closed	0 $0
Q4 2017 Jan 30, 2018	BUY	$358.63 - $469.95 $221,633 - $290,429	618 Added 78.53%	1,405 $528,000
Q3 2017 Nov 09, 2017	BUY	$431.38 - $504.0 $339,496 - $396,648	787	787 $352,000

Others Institutions Holding REGN

# of Institutions

1,484

Shares Held

83.7M

Call Options Held

1.22M

Put Options Held

1.5M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $76.1B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lmr Partners LLP, based on Form 13F filings with the SEC.

News

Stay updated on Lmr Partners LLP with notifications on news.

Account